VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.12% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-12
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-06-30 was 4.12%, a 1.23% increase year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-12-31 was 3.55%, a 17.82% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-09-30 was 3.83%, a 5.22% increase year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 4.07%, a 8.95% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2026 was 3.68%, a 1.87% decline from fiscal 2025.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 3.75%, a 8.76% decline from fiscal 2024.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.11%, a 23.80% increase from fiscal 2023.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.32%, a 155.38% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 4.12% 10-Q · filed 2026-08-12 | |||||
| 2026-03-31 | 3.68% 10-K · filed 2026-07-14 | |||||
| 2025-12-31 | 3.55% 10-Q · filed 2026-02-11 | 3.70% 10-Q · filed 2026-02-11 | ||||
| 2025-09-30 | 3.83% 10-Q · filed 2025-11-06 | 3.87% 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 4.07% 10-Q · filed 2026-08-12 | |||||
| 2025-03-31 | 3.75% 10-K · filed 2026-07-14 | |||||
| 2024-12-31 | 4.32% 10-Q · filed 2026-02-11 | 3.75% 10-Q · filed 2026-02-11 | ||||
| 2024-09-30 | 3.64% 10-Q · filed 2025-11-06 | 3.75% 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | 4.47% 10-Q · filed 2025-08-12 | |||||
| 2024-03-31 | 4.11% 10-K · filed 2025-06-05 | |||||
| 2023-12-31 | 4.66% 10-Q · filed 2025-02-19 | 4.12% 10-Q · filed 2025-02-19 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-08 | 3.95% 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | 3.95% 10-Q · filed 2024-08-05 | |||||
| 2023-03-31 | 3.32% 10-K · filed 2024-05-31 | |||||
| 2022-12-31 | 3.97% 10-Q · filed 2024-02-08 | 3.21% 10-Q · filed 2024-02-08 | ||||
| 2022-09-30 | 3.30% 10-Q · filed 2023-11-09 | 3.18% 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 2.97% 10-Q · filed 2023-08-10 | |||||
| 2022-03-31 | 1.30% 10-K · filed 2023-07-14 | |||||
| 2021-12-31 | 1.20% 10-Q · filed 2023-02-09 | 1.19% 10-Q · filed 2022-02-14 | ||||
| 2021-09-30 | 0.73% 10-Q · filed 2022-11-10 | 0.73% 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | 0.61% 10-K · filed 2022-06-10 | |||||
| 2020-12-31 | 0.33% 10-Q · filed 2022-02-14 | 0.27% 10-Q · filed 2022-02-14 | ||||
| 2020-09-30 | 0.27% 10-Q · filed 2021-11-08 | 0.27% 10-Q · filed 2021-11-08 | ||||
| 2020-03-31 | 1.53% 10-K · filed 2021-06-15 | |||||
| 2019-12-31 | 0.00% 10-Q · filed 2021-02-08 | 1.53% 10-Q · filed 2021-02-08 | ||||
| 2019-09-30 | 1.53% 10-Q · filed 2020-11-05 | 1.53% 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-08 | |||||
| 2019-03-31 | 2.75% 10-K · filed 2020-05-28 | |||||
| 2018-12-31 | 2.79% 10-Q · filed 2020-02-10 | 2.75% 10-Q · filed 2020-02-10 | ||||
| 2018-09-30 | 2.74% 10-Q · filed 2019-11-07 | 2.75% 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 2.82% 10-Q · filed 2019-08-08 | |||||
| 2018-03-31 | 1.81% 10-K · filed 2019-06-03 | |||||
| 2017-12-31 | 2.15% 10-Q · filed 2019-02-07 | 1.81% 10-Q · filed 2019-02-07 | ||||
| 2017-09-30 | 1.78% 10-Q · filed 2018-11-08 | 1.81% 10-Q · filed 2018-11-08 | ||||
| 2017-06-30 | 1.62% 10-Q · filed 2018-08-09 | |||||
| 2017-03-31 | 1.16% 10-K · filed 2018-05-31 | |||||
| 2016-12-31 | 1.68% 10-Q · filed 2018-02-08 | 1.13% 10-Q · filed 2018-02-08 | ||||
| 2016-09-30 | 1.07% 10-Q · filed 2017-11-09 | 1.10% 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | 1.20% 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | 1.57% 10-K · filed 2018-05-31 | |||||
| 2015-12-31 | 1.64% 10-Q · filed 2017-02-09 | 1.61% 10-Q · filed 2017-02-09 | ||||
| 2015-09-30 | 1.48% 10-Q · filed 2016-11-03 | 1.60% 10-Q · filed 2016-11-03 | ||||
| 2015-06-30 | 1.65% 10-Q · filed 2016-08-04 | |||||
| 2015-03-31 | 1.60% 10-K · filed 2017-06-07 | |||||
| 2014-12-31 | 1.67% 10-Q · filed 2016-02-08 | 1.64% 10-Q · filed 2016-02-08 | ||||
| 2014-11-30 | 1.21% 10-K · filed 2019-06-03 | 1.65% 10-Q · filed 2015-02-06 | ||||
| 2014-09-30 | 1.66% 10-Q · filed 2015-11-09 | 1.61% 10-Q · filed 2015-11-09 | ||||
| 2014-06-30 | 1.56% 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | 1.32% 10-K · filed 2015-06-09 | |||||
| 2013-12-31 | 0.78% 10-Q · filed 2015-02-06 | 0.82% 10-Q · filed 2015-02-06 | ||||
| 2013-11-30 | 0.60% 10-Q · filed 2014-11-07 | |||||
| 2013-09-30 | 0.63% 10-Q · filed 2014-11-07 | 0.84% 10-Q · filed 2014-11-07 | ||||
| 2013-06-30 | 1.04% 10-Q · filed 2014-08-08 | |||||
| 2013-03-31 | 1.19% 10-K · filed 2014-06-10 | |||||
| 2012-12-31 | 0.89% 10-Q · filed 2014-02-06 | 1.04% 10-Q · filed 2014-02-06 | 0.89% 10-K · filed 2014-06-10 | |||
| 2012-09-30 | 0.82% 10-Q · filed 2013-11-08 | 1.01% 10-Q · filed 2013-11-08 | 0.88% 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | 1.21% 10-Q · filed 2013-08-09 | 1.21% 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | 1.07% 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |